Evidence map›Paper›PMID 29088245›Full record

ArticlePloS one2017

Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract.

Jeroen L A van Vugt, Stefan Buettner, Stef Levolger, Robert R J Coebergh van den Braak, Mustafa Suker, Marcia P Gaspersz, Ron W F de Bruin, Cornelis Verhoef, Casper H C van Eijck, Niek Bossche and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Observational
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Sarcopenia and mortality in cancer: A meta-analysis.Osteoporosis and sarcopenia · 2021
    Article
  12. Review
  13. Article
  14. Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jeroen L A van VugtDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0003-0033-9947
Stefan BuettnerDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Stef LevolgerDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Robert R J Coebergh van den BraakDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Mustafa SukerDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Marcia P GasperszDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Ron W F de BruinDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Cornelis VerhoefDepartment of Control and Compliance, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Casper H C van EijckDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Niek BosscheDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Bas Groot KoerkampDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Jan N M IJzermansDepartment of Surgery, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Erasmus MC · NLErasmus MC Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLow skeletal muscle mass is associated with poor postoperative outcomes in cancer patients. Furthermore, it is associated with increased healthcare costs in the United States. We investigated its effect on hospital expenditure in a Western-European healthcare system, with universal access.

methodsSkeletal muscle mass (assessed on CT) and costs were obtained for patients who underwent curative-intent abdominal cancer surgery. Low skeletal muscle mass was defined based on pre-established cut-offs. The relationship between low skeletal muscle mass and hospital costs was assessed using linear regression analysis and Mann-Whitney U-tests.

results452 patients were included (median age 65, 61.5% males). Patients underwent surgery for colorectal cancer (38.9%), colorectal liver metastases (27.4%), primary liver tumours (23.2%), and pancreatic/periampullary cancer (10.4%). In total, 45.6% had sarcopenia. Median costs were €2,183 higher in patients with low compared with patients with high skeletal muscle mass (€17,144 versus €14,961; P<0.001). Hospital costs incrementally increased with lower sex-specific skeletal muscle mass quartiles (P = 0.029). After adjustment for confounders, low skeletal muscle mass was associated with a cost increase of €4,061 (P = 0.015).

conclusionLow skeletal muscle mass was independently associated with increased hospital costs of about €4,000 per patient. Strategies to reduce skeletal muscle wasting could reduce hospital costs in an era of incremental healthcare costs and an increasingly ageing population.

Indexed as

Organ SizeAgedDigestive System NeoplasmsFemaleHospital CostsHumansMaleMiddle AgedMuscle, SkeletalTreatment Outcome

Identifiers

PMID29088245
PMCPMC5663377
OpenAlexW2766615261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.